JAMIE CANNON: Open Payments
NPI 1467186403 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 18 payments from 12 companies in 2025. Trend: 2023 $639 · 2024 $599 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: Kerendia, PAXLOVID, JARDIANCE, CAPLYTA, Heplisav-B, KISUNLA, REXULTI, TZIELD.
Industry payments across KY — which companies pay providers there.
